Virtu Financial’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,149
| Closed | -$146K | – | 1430 |
|
|
2024
Q1 | $146K | Sell |
3,149
-1,810
| -36% | -$83.9K | 0.01% | 856 |
|
|
2023
Q4 | $335K | Sell |
4,959
-4,434
| -47% | -$300K | 0.03% | 562 |
|
|
2023
Q3 | $680K | Buy |
+9,393
| New | +$680K | 0.07% | 266 |
|
|
2023
Q2 | – | Sell |
-11,129
| Closed | -$592K | – | 1624 |
|
|
2023
Q1 | $592K | Buy |
11,129
+10,471
| +1,591% | +$557K | 0.06% | 298 |
|
|
2022
Q4 | $44K | Sell |
658
-2,560
| -80% | -$171K | 0.01% | 1106 |
|
|
2022
Q3 | $402K | Sell |
3,218
-7,546
| -70% | -$943K | 0.04% | 499 |
|
|
2022
Q2 | $1.03M | Buy |
+10,764
| New | +$1.03M | 0.09% | 219 |
|
|
2022
Q1 | – | Sell |
-2,174
| Closed | -$722K | – | 1617 |
|
|
2021
Q4 | $722K | Sell |
2,174
-1,304
| -37% | -$433K | 0.07% | 255 |
|
|
2021
Q3 | $1.61M | Buy |
+3,478
| New | +$1.61M | 0.14% | 128 |
|